CHROMONE-6-BORONIC ACID PINACOL ESTER(928773-42-6)
- Name: CHROMONE-6-BORONIC ACID PINACOL ESTER
- Synonyms:CHROMONE-6-BORONIC ACID PINACOL ESTER;
- Molecular Formula:C15H17BO4
- Molecular Weight:272.10400
- CAS Registry Number:928773-42-6
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 928773-11-9/1-Azabicyclo[2.2.2]octane, 3-[[6-(2-methyl-1H-indol-5-yl)-3-pyridazinyl]oxy]-, 2,2,2-trifluoroacetate (1:?), (3R)-
- 928773-35-7/1-Azabicyclo[2.2.2]octane, 3-[[6-(2,3-dihydro-1H-inden-5-yl)-3-pyridazinyl]oxy]-, 2,2,2-trifluoroacetate (1:1), (3R)-
- 928773-36-8/1-Azabicyclo[2.2.2]octane, 3-[[6-(2-chloro-1H-indol-5-yl)-3-pyridazinyl]oxy]-, (3R)-
- 928773-38-0/1-Azabicyclo[2.2.2]octane, 3-[[6-(1H-inden-5-yl)-3-pyridazinyl]oxy]-, 2,2,2-trifluoroacetate (1:1), (3R)-
- 928773-41-5/1,3,2-Dioxaborolane, 2-(1H-inden-5-yl)-4,4,5,5-tetramethyl-
- 928773-42-6/CHROMONE-6-BORONIC ACID PINACOL ESTER
- 928774-54-3/Benzamide, 4-(6-cyclopentyl-5,6,7,8-tetrahydropyrazolo[3,4-d]azepin-2(4H)-yl)-N,N- dimethyl-
- 928774-55-4/Benzamide, N-methyl-4-[5,6,7,8-tetrahydro-6-(2-methylpropyl)pyrazolo[3,4-d]azepin- 2(4H)-yl]-
- 928774-65-6/Pyrazolo[3,4-d]azepine, 2,4,5,6,7,8-hexahydro-6-(1-methylethyl)-2-[4-(3-methyl-1,2,4-oxadiazol- 5-yl)phenyl]-
- 928774-66-7/Benzamide, 4-[5,6,7,8-tetrahydro-6-(2-methylpropyl)pyrazolo[3,4-d]azepin-2(4H)-yl]-
- 928774-68-9/2-Pyrrolidinone, 1-[4-(6-ethyl-5,6,7,8-tetrahydropyrazolo[3,4-d]azepin-2(4H)-yl)phenyl]-
- 928774-70-3/2-Pyrrolidinone, 1-[4-[5,6,7,8-tetrahydro-6-(2-methylpropyl)pyrazolo[3,4-d]azepin-2(4H)- yl]phenyl]-
- 928774-71-4/Pyrazolo[3,4-d]azepine, 2,4,5,6,7,8-hexahydro-2-[4-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]-6-(2- methylpropyl)-
- 928774-73-6/Benzamide, 4-(6-cyclopentyl-5,6,7,8-tetrahydropyrazolo[3,4-d]azepin-2(4H)-yl)-
- 928774-76-9/Benzamide, 4-(6-cyclobutyl-5,6,7,8-tetrahydropyrazolo[3,4-d]azepin-2(4H)-yl)-
- 928774-77-0/Pyrazolo[3,4-d]azepine, 6-cyclopentyl-2,4,5,6,7,8-hexahydro-2-[4-(3-methyl-1,2,4-oxadiazol-5-yl) phenyl]-
- 928774-78-1/Pyrazolo[3,4-d]azepine, 6-cyclobutyl-2,4,5,6,7,8-hexahydro-2-[4-(methylsulfonyl)phenyl]-
- 928774-82-7/Benzonitrile, 4-(6-cyclobutyl-5,6,7,8-tetrahydropyrazolo[3,4-d]azepin-2(4H)-yl)-
- 928774-83-8/Benzonitrile, 4-[5,6,7,8-tetrahydro-6-(2-methylpropyl)pyrazolo[3,4-d]azepin-2(4H)-yl]-
- 928774-85-0/Pyrazolo[3,4-d]azepine, 2-(4-bromophenyl)-6-cyclobutyl-2,4,5,6,7,8-hexahydro-
- 928774-89-4/Pyrazolo[3,4-d]azepine, 6-cyclobutyl-2,4,5,6,7,8-hexahydro-2-[4-(4-morpholinyl)phenyl]-
- 928774-90-7/Pyrazolo[3,4-d]azepine, 6-cyclobutyl-2,4,5,6,7,8-hexahydro-2-[4-(1-piperidinyl)phenyl]-
- 928774-91-8/Pyrazolo[3,4-d]azepine, 6-cyclobutyl-2,4,5,6,7,8-hexahydro-2-[4-(1-pyrrolidinyl)phenyl]-
- 928773-33-5/1-Azabicyclo[2.2.2]octane, 3-[[6-(2-benzofuranyl)-3-pyridazinyl]oxy]-, 2,2,2-trifluoroacetate (1:1), (3R)-
- 928773-31-3/1-Azabicyclo[2.2.2]octane, 3-[[6-(5-benzofuranyl)-3-pyridazinyl]oxy]-, 2,2,2-trifluoroacetate (1:1), (3R)-
- 928773-29-9/1-Azabicyclo[2.2.2]octane, 3-[[6-(2-naphthalenyl)-3-pyridazinyl]oxy]-, 2,2,2-trifluoroacetate (1:1), (3R)-
- 928773-26-6/1-Azabicyclo[2.2.2]octane, 3-[[6-(1H-indazol-5-yl)-3-pyridazinyl]oxy]-, 2,2,2-trifluoroacetate (1:?), (3S)-
- 928773-25-5/1-Azabicyclo[2.2.2]octane, 3-[[6-(1H-indazol-5-yl)-3-pyridazinyl]oxy]-, (3S)-
- 928773-23-3/1-Azabicyclo[2.2.2]octane, 3-[[6-(1H-indazol-5-yl)-3-pyridazinyl]oxy]-, (3R)-, (2E)-2-butenedioate (1:?)
- 928773-22-2/1-Azabicyclo[2.2.2]octane, 3-[[6-(1H-indazol-5-yl)-3-pyridazinyl]oxy]-, (3R)-